Trials / Completed
CompletedNCT01166646
Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the investigational lotion is an effective treatment of moderate to severe plaque psoriasis in comparison to an approved cream.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Halobetasol Proprionate Lotion 0.05% | Apply 3.5 grams twice daily for 1-2 weeks |
| DRUG | Halobetasol Proprionate Cream 0.05% | Apply 3.5 grams twice daily for 1-2 weeks |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2010-07-21
- Last updated
- 2016-05-16
- Results posted
- 2016-05-16
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01166646. Inclusion in this directory is not an endorsement.